Monocyte populations as markers of response to adalimumab plus MTX in rheumatoid arthritis

INTRODUCTION: The treatment of rheumatoid arthritis (RA) patients with anti-tumor necrosis factor alpha (TNFα) biological drugs has dramatically improved the prognosis of these patients. However, a third of the treated patients do not respond to this therapy. Thus, the search for biomarkers of clini...

Descripción completa

Detalles Bibliográficos
Autores principales: Chara, Luis, Sánchez-Atrio, Ana, Pérez, Ana, Cuende, Eduardo, Albarrán, Fernando, Turrión, Ana, Chevarria, Julio, Sánchez, Miguel A, Monserrat, Jorge, de la Hera, Antonio, Prieto, Alfredo, Sanz, Ignacio, Diaz, David, Alvarez-Mon, Melchor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3580569/
https://www.ncbi.nlm.nih.gov/pubmed/22838733
http://dx.doi.org/10.1186/ar3928

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3580569/
https://www.ncbi.nlm.nih.gov/pubmed/22838733
http://dx.doi.org/10.1186/ar3928

Ejemplares similares